As more biosimilar drugs come to the Canadian market, decision-makers need information to help guide prescribing and policy development. Are biosimilars the same as their reference drugs? Can they improve access for patients? What’s the difference between interchangeability and switching? Read on for more information, or get our patient handout.

ORGANIZATION:

RESOURCE TYPE:
FACTSHEET

Skills